Analyze Portfolio
NYSE · Healthcare

Cigna Group (CI)

As-reported financials and recent SEC filings for Cigna Group, latest fiscal period FY2025. Financial statements come straight from the company’s EDGAR filings; valuation figures such as P/E and market cap use market data.

Snapshot

Revenue
$274.90B
Revenue growth (YoY)
11.2%
Net income
$5.96B
Diluted EPS
$22.18
Gross margin
Operating margin
3.3%
Net margin
2.2%
FCF margin
ROE
14.2%
P/E (TTM)
12.3×
Market cap
$76.98B
Debt / equity
0.7×

Fundamentals are from SEC filings. P/E and market cap are derived from recent market prices, refreshed on a rolling basis (typically within the past week).

What changed at Cigna Group

  • Revenue grew 11.2% to $274.9B in FY2025, slower than the 26.6% the year before.
  • Operating margin is 3.3% in FY2025, -1.2 pp against 4.6% in FY2021.
  • Most recent quarter Q1 FY2026: revenue $68.5B, up 4.6% from Q1 FY2025.
  • Net income rose 73.5% to $6.0B in FY2025.

Computed from the as-reported figures in the statements below. A change we cannot state from filed figures is left out rather than estimated.

Peer comparison

Where Cigna Group’s fundamentals sit among the 558 Healthcare companies. Each figure is ranked only against peers that report it, from lowest (left) to highest (right).

Operating margin3.3%
56th percentile of 397
Net margin2.2%
57th percentile of 416
Revenue growth (YoY)+11.2%
53rd percentile of 538
ROE14.2%
80th percentile of 474
P/E (TTM)12.3×
23rd percentile of 203
Debt / equity0.74×
67th percentile of 243
Short interest4.31d
41st percentile of 557

No open-market insider buys in the last 90 days; 14 insider sales totaling $59.4M. For context, about 16% of companies in the universe saw any open-market insider buying in the same window. Browse insider activity →

Percentiles describe where a figure sits among sector peers reporting it (100th = highest). They are position within a peer group, not a rating, and not investment advice. Short interest ranking uses days to cover from FINRA Consolidated Short Interest data; FINRA is the owner and source of that data, included at no additional charge.

Institutional ownership

Held by 4 of the superinvestors we track (plus 7 quant / multi-strat books), based on each investor’s most recent 13F (latest Q1 2026).

Conviction investors
4
+7 quant / multi-strat
Initiated / added
6
0 new, 6 added
Reduced / exited
5
5 trimmed, 0 exited
Combined position
$4.23B
reported long value
InvestorAs ofPosition valueSharesChange
Dodge & CoxQ1 2026$3.08B11.6MAdded
AQR Capital ManagementquantQ1 2026$672.4M2.6MAdded
Two Sigma InvestmentsquantQ1 2026$171.1M641.3KAdded
Citadel AdvisorsquantQ1 2026$88.8M333.0KReduced
Bridgewater AssociatesQ1 2026$61.0M228.5KReduced
Renaissance TechnologiesquantQ1 2026$58.4M218.9KAdded
Millennium ManagementquantQ1 2026$33.5M125.6KAdded
Gotham Asset ManagementQ1 2026$26.9M100.8KAdded
Greenlight CapitalQ1 2026$23.6M88.4KReduced
Point72 Asset ManagementquantQ1 2026$7.5M28.3KReduced
D. E. ShawquantQ1 2026$6.6M24.6KReduced

From quarterly Form 13F filings, which can be up to 45 days delayed. Long US-listed positions only: excludes short positions, options, cash, bonds, and non-US holdings, so this is not a manager’s complete portfolio. Counts are of the investors we track, not all institutions. Not investment advice.

Recent insider activity

Non-derivative buys and sells (codes P/S) reported by officers, directors and 10% owners on SEC Form 4.

Buys (90d)
0
open-market
Bought (90d)
open-market value
Sells (90d)
14
$59.4M
Signal
Net selling
by $ value, 90d
Trade dateInsiderTypeSharesPriceValue
2026-06-12
filed 2026-06-16
Kates Jamie GChief Accounting OfficerSell899$298.61$268K
2026-05-12
filed 2026-05-14
Cordani DavidChairman & CEOSell41.1K$290.00$11.9M
2026-05-12
filed 2026-05-14
Cordani DavidChairman & CEOSell38.5K$294.98$11.4M
2026-05-12
filed 2026-05-14
Cordani DavidChairman & CEOSell34.6K$295.98$10.3M
2026-05-12
filed 2026-05-14
Cordani DavidChairman & CEOSell15.3K$298.24$4.6M
2026-05-12
filed 2026-05-14
Cordani DavidChairman & CEOSell14.3K$287.96$4.1M
2026-05-12
filed 2026-05-14
Cordani DavidChairman & CEOSell13.8K$288.85$4.0M
2026-05-12
filed 2026-05-14
Cordani DavidChairman & CEOSell13.7K$291.01$4.0M
2026-05-12
filed 2026-05-14
Cordani DavidChairman & CEOSell12.3K$291.95$3.6M
2026-05-12
filed 2026-05-14
Cordani DavidChairman & CEOSell7.9K$292.88$2.3M
2026-05-12
filed 2026-05-14
Cordani DavidChairman & CEOSell3.9K$286.83$1.1M
2026-05-12
filed 2026-05-14
Cordani DavidChairman & CEOSell2.2K$298.53$666K

Reported non-derivative purchases and sales (codes P/S) — which may be open-market or private; excludes option exercises, grants, and shares withheld for taxes. Dates shown are the trade date; a Form 4 can be filed days to years later. A sale can be routine (e.g. a pre-set 10b5-1 plan), so read individual transactions in context. From SEC Form 4. Not investment advice.

Short interest

Total shares sold short as of each twice-monthly FINRA settlement. Rising short interest means more investors are positioned against the stock; days to cover estimates how many trading days of average volume that position represents.

Shares short
6.2M
settled 2026-07-15
Change vs prior
-0.8%
vs previous settlement
Days to cover
4.31
at avg daily volume
Avg daily volume
1.4M
FINRA reported
SettlementShares shortChangeDays to cover
2026-07-156.2M-0.8%4.31
2026-06-306.2M-15.1%3.55
2026-06-157.3M+21.2%4.95
2026-05-296.1M-1.2%3.84
2026-05-156.1M-3.4%3.34
2026-04-306.3M-1.2%3.70
2026-04-156.4M-5.7%5.58
2026-03-316.8M+6.2%3.51

Source: FINRA Consolidated Short Interest. FINRA is the owner and source of the FINRA-supplied data, which is included at no additional charge for your own personal or professional use; republishing or redistributing it is not permitted. Settlement dates are shown; FINRA publishes each settlement about nine business days later, so the latest figure can be two to four weeks old. Not presented as a percentage of float. No FINRA endorsement of this product is implied. Not investment advice.

Income statement (as reported)

 FY2025FY2024FY2023FY2022FY2021
Revenue$274.90B$247.12B$195.26B$180.52B$174.07B
Gross profit
Operating income$9.20B$9.42B$8.54B$8.45B$7.94B
Net income$5.96B$3.43B$5.16B$6.78B$5.42B
Diluted EPS$22.18$12.12$17.39$21.41$15.75

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full methodology.

Balance sheet (as reported)

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full methodology.

Cash flow (as reported)

 FY2025FY2024FY2023FY2022FY2021
Operating cash flow$9.60B$10.36B$11.81B$8.66B$7.19B
Capital expenditure
Free cash flow

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full methodology.

Quarterly trend (as reported)

QuarterRevenueRevenue YoYNet incomeDiluted EPS
Q1 FY2026$68.49B4.6%$1.65B$6.26
Q4 FY2025$72.47B10.4%$4.66
Q3 FY2025$69.75B9.5%$1.97B$6.98
Q2 FY2025$67.18B11.0%$1.63B$5.71
Q1 FY2025$65.50B14.4%$1.32B$4.85
Q4 FY2024$65.65B28.4%$5.07
Q3 FY2024$63.69B29.9%$825.0M$2.63
Q2 FY2024$60.52B24.6%$1.63B$5.45

Latest 8 reported quarters, from company XBRL filings on SEC EDGAR.

Company facts

ExchangeNYSE
SectorHealthcare
SIC industryHospital & Medical Service Plans
Fiscal year endDecember 31
Latest fiscal periodFY2025
SEC filings since2018
SEC CIK1739940

Recent SEC filings

10-K2026-02-26
View on EDGAR →
10-K2025-02-27
View on EDGAR →
10-Q2026-04-30
View on EDGAR →
10-Q2025-10-30
View on EDGAR →
10-Q2025-07-31
View on EDGAR →
10-Q2025-05-02
View on EDGAR →
8-K2026-05-13
View on EDGAR →
8-K2026-04-30
View on EDGAR →

Largest Healthcare peers

All Healthcare companies →

CI head to head

Monitor CI

Get an alert when Cigna Group files something material, see which superinvestors own it, and ask its filings a question with cited answers.

Monitor CI free

Includes one free filing-grounded research answer. Or check your whole portfolio, no account needed.

Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only. Not investment advice.